Scholar: Thomas Vogl

Thomas Vogl

Video highlight

Systemic antibody responses against human microbiota flagellins are overrepresented in chronic fatigue syndrome patients

  • Thomas Vogl, Iris N Kalka, Shelley Klompus, Sigal Leviatan, Adina Weinberger, Eran Segal
  • Sci Adv, 10.1126/sciadv.abq2422
Read More

Cross-reactive antibodies against human coronaviruses and the animal coronavirome suggest diagnostics for future zoonotic spillovers

  • Shelley Klompus, Sigal Leviatan, Thomas Vogl, …, Adina Weinberger, Ziv Shulman, Eran Segal
  • Sci Immunol, 10.1126/sciimmunol.abe9950
Read More

Disulfide bond engineering of AppA phytase for increased thermostability requires co-expression of protein disulfide isomerase in Pichia pastoris

  • Laura Navone, Thomas Vogl, Pawarisa Luangthongkam, …, Juhani von Hellens, Stephen Mahler, Robert Speight
  • None, 10.1186/s13068-021-01936-8
Read More

SARS-CoV-2 antibody testing for estimating COVID-19 prevalence in the population

Read More

Synergistic optimisation of expression, folding, and secretion improves E. coli AppA phytase production in Pichia pastoris

  • Laura Navone, Thomas Vogl, Pawarisa Luangthongkam, …, Xiaojing Chen, Juhani von Hellens, Robert Speight
  • Microb Cell Fact, 10.1186/s12934-020-01499-7
Read More

Orthologous promoters from related methylotrophic yeasts surpass expression of endogenous promoters of Pichia pastoris

  • Thomas Vogl, Jasmin Elgin Fischer, Patrick Hyden, Richard Wasmayer, Lukas Sturmberger, Anton Glieder
  • None, 10.1186/s13568-020-00972-1
Read More

Engineered bidirectional promoters enable rapid multi-gene co-expression optimization

  • Thomas Vogl, Thomas Kickenweiz, Julia Pitzer, …, Martina Geier, Parayil Kumaran Ajikumar, Anton Glieder
  • Nat Commun, 10.1038/s41467-018-05915-w
Read More

Implementing CRISPR-Cas technologies in conventional and non-conventional yeasts: Current state and future prospects

Read More